Clinical Trial Update: Canadian Biomarker Integration Network for Depression Study [Phase 3]

View source ↗

Summary

Phase 3 CAN-BIND study evaluating biomarkers in Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University Health Network, Toronto | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED